The company's experimental once-daily version will become the first oral GLP-1 for chronic weight management, if approved.

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

A decision is expected in the fourth quarter of 2025.

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Taking Ozempic helps slow down your digestion, making you feel fuller and thus reducing your hunger, which in turn can help ...

The WHO's conditional recommendation will be officially released in August, as part of new guidelines on treating obesity. It is also working on separate guidelines for children and adolescents.

High-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...

Kyle Richards’ daughter Sophia Umansky detailed the unexpected side effects that surfaced four months after she started ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...